STOCK TITAN

Vuzix (VUZI) Stock News

VUZI Nasdaq

Welcome to our dedicated page for Vuzix news (Ticker: VUZI), a resource for investors and traders seeking the latest updates and insights on Vuzix stock.

Vuzix Corporation develops and supplies AI-powered smart glasses, waveguides and augmented reality display technologies for enterprise, medical, defense, security and select consumer markets. News about VUZI commonly covers smart-glasses deployments, follow-on customer orders, OEM waveguide programs, product demonstrations, reseller relationships and business updates tied to its wearable computing and optical display platforms.

Recurring developments include M400, LX1, Z100 and Ultralite Pro platform activity, warehouse and logistics workflows, veterinary medical remote-support applications, and waveguide-based head-mounted display systems for aerospace and defense customers. Company updates also address financial results calls and partner solutions that pair Vuzix waveguides with third-party projector and optical module technologies.

Rhea-AI Summary

Vuzix Corporation (NASDAQ: VUZI) announced the successful delivery of a customized waveguide-based optics engine as part of a Phase 1 non-recurring engineering agreement established in March 2020. The delivery was completed ahead of schedule, indicating strong potential for future agreements and volume production orders. CEO Paul Travers expressed optimism about the customer relationship and anticipated future project phases that could enhance business prospects for Vuzix.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.83%
Tags
none
-
Rhea-AI Summary

Vuzix Corporation (NASDAQ: VUZI) announced that its M400 Smart Glasses have received CCC certification for sale in China. This certification opens significant market opportunities in China, particularly in supporting COVID-19 business continuity. The M400 features advanced camera technology, a rugged design, and Chinese-native voice recognition, making it suitable for harsh environments. CEO Paul Travers highlighted the importance of smart glasses in providing effective solutions during the pandemic. Vuzix aims to leverage its position in the AR industry to address growing demand in China.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.8%
Tags
covid-19
-
Rhea-AI Summary

On June 30, 2020, Vuzix Corporation announced the successful completion of the world's first total knee replacement surgery using its M400 Smart Glasses on June 24, in collaboration with Pixee Medical. The glasses provided real-time navigation and augmented reality data to the surgeon. Pixee Medical expects a rapid increase in surgeries utilizing this technology, with plans for distribution agreements and FDA approval anticipated by the end of 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.58%
Tags
none
News
Rhea-AI Summary

Vuzix Corporation (NASDAQ: VUZI) issued a June 2020 Letter to Shareholders, highlighting the surge in interest and sales for its enterprise and medical smart glasses amidst COVID-19. Key updates include the planned volume production of the M4000 smart glasses, enhanced waveguide manufacturing, and increased engineering services contracts. Vuzix holds 157 patents, asserting its position in smart glass technology. The letter emphasizes adaptability to COVID-19 impacts and discusses upcoming telemedicine opportunities. CEO Paul Travers expressed optimism about future advancements in the smart glasses industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.69%
Tags
none

FAQ

What is the current stock price of Vuzix (VUZI)?

The current stock price of Vuzix (VUZI) is $3.08 as of June 23, 2026.

What is the market cap of Vuzix (VUZI)?

The market cap of Vuzix (VUZI) is approximately 275.3M.